Webb3 juli 2024 · Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in patients receiving immunotherapy for non-small-cell lung cancer. In this paper, we describe three cases of immunotherapy-induced … Webb1 aug. 2024 · Abstract. Immune-checkpoint inhibitors (ICI), particularly inhibitors of the PD-1 axis, have altered the management of non–small cell lung cancer (NSCLC) over the …
Does immunotherapy work for small cell lung cancer?
Webb1 nov. 2024 · Small cell lung cancer (SCLC) arises in peribronchial locations and infiltrates the bronchial submucosa, including about 15% of lung cancer cases. Despite decades of … Webb2 aug. 2024 · In the last decade, immunotherapy has shown itself to be a viable therapeutic approach for non-small cell lung cancer (NSCLC). Several clinical trials have established … fisheries and oceans burlington
The National Institutes of Health on LinkedIn: New Tool Predicts ...
WebbFor more than three decades, care for small-cell lung cancer (SCLC) remained mostly the same. That’s changing now -- doctors have a new option called immunotherapy. Webb7 maj 2024 · Small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. There are two main types of small cell lung cancer. Smoking is the major risk factor for small cell … Webb5 apr. 2024 · Immunotherapy has shown promise in the treatment of small cell lung cancer (SCLC). SCLC is an aggressive form of lung cancer that is often treated with chemotherapy and radiation therapy. However, these treatments can weaken the immune system, … fisheries and oceans canada dfo-mpo.gc.ca